Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $90.2300 (0.8%) ($89.0000 - $91.7400) on Tue. Feb. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.31% (three month average) | RSI | 48 | Latest Price | $90.2300(0.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.5% a day on average for past five trading days. | Weekly Trend | LGND declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(58%) IWC(55%) XBI(55%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.155% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-14%) UUP(-5%) SHY(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.155% (StdDev 2.31%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
Resistance Level | $90.89 | 5 Day Moving Average | $89.34(1%) | 10 Day Moving Average | $89.09(1.28%) | 20 Day Moving Average | $90.89(-0.73%) | To recent high | -20.2% | To recent low | 4.3% | Market Cap | $1.45b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |